Does aspirin 6 h after coronary artery bypass grafting optimise graft patency?

Area of Science:

• Cardiovascular Surgery
• Pharmacology
• Evidence-Based Medicine

Background:

• Coronary artery bypass grafting (CABG) is a critical procedure for managing coronary artery disease.
• Graft patency is a key determinant of long-term success after CABG.
• Postoperative medication strategies, including aspirin use, are crucial for optimizing outcomes.

Purpose of the Study:

• To evaluate the optimal timing of aspirin administration following CABG to maximize graft patency.
• To assess the impact of early versus delayed aspirin initiation on graft occlusion and bleeding complications.

Main Methods:

• A systematic literature search identified 201 relevant papers.
• Seven high-quality studies were selected based on predefined criteria for best evidence.
• Data on study design, patient characteristics, interventions, and outcomes were extracted and tabulated.

Main Results:

• Aspirin administered less than 6 hours post-CABG demonstrated optimal reduction in graft occlusion.
• Early aspirin initiation did not significantly increase the risk of postoperative bleeding.
• The evidence supports early aspirin use for improving graft patency.

Conclusions:

• Administering aspirin within 6 hours after CABG is an effective strategy to optimize graft patency.
• Early postoperative aspirin use is safe and does not elevate bleeding complications.
• This finding provides strong evidence for clinical practice guidelines in cardiac surgery.